Company Overview and News

 
UAE fund Mubadala in talks for Odebrecht-run rail operator Supervia- sources

2018-03-15 reuters
SAO PAULO (Reuters) - United Arab Emirates’ sovereign wealth fund Mubadala Development Co [MUDEV.UL] is keen to acquire a majority stake in Brazilian suburban rail operator Supervia, controlled by conglomerate Odebrecht SA, three sources with knowledge of the matter said.
Upvote Downvote

 
As Stock Jitters Recede, Focus Shifts to Surging Company Profits - Bloomberg

2018-02-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
140 Successful Tests and Several ''Firsts'' for Vinci, the Engine for Ariane 6

2018-02-16 asdnews
The re-ignitable Vinci®, engine, which will power the upper stage of the Ariane 6 launcher, has now successfully completed its last two subsystems qualification campaigns (M6 and M7) with 140 engine tests conducted. The tests in campaigns M6 and M7, vital for qualification of the engine subsystems, were carried out on the PF52 bench at the ArianeGroup site in Vernon, France, and on the German Aerospace Center DLR’s P4.
Upvote Downvote

 
Bloomberg’s Week in Pictures - Bloomberg

2018-01-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Catalonia’s Other Showdown: A Corporate Tussle Over Toll Roads - Bloomberg

2017-10-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Paris Faces Tough Choice Between Olympics and Angry Commuters - Bloomberg

2017-10-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Paris 2024 Olympics Triggers Race for Contracts Worth Billions - Bloomberg

2017-09-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Focus on Ivy International Core Equity Fund Class Y (IVVYX)

2017-05-01 zacks
Ivy International Core Equity Fund Class Y (IVVYX - Free Report) seeks long-term capital growth. The fund invests at least 80% of its net assets in equity securities including common stock, preferred stock and securities convertible into common stock) principally traded in European, Pacific Basin and Latin American markets.
Upvote Downvote

 
The Optimal Range To Reach For Yield

2017-04-05 seekingalpha
Heartland Advisors is out with a white paper showing buying the 2nd quintile highest yielding stocks works better.
Upvote Downvote

 
Paris Boycotts LafargeHolcim in Protest Over Trump's Mexico Wall - Bloomberg

2017-03-31 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Trump’s Wall Is 30 Feet of Scary Politics for Builders - Bloomberg

2017-03-24 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Brazil's $1 Billion Airport Mega-Auction Is Greeted With a Yawn - Bloomberg

2017-03-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
MOVES-Laurent Kssis named XBT Provider interim managing director

2017-03-13 reuters
March 13 Asset management firm Global Advisors (Jersey) Ltd has appointed Laurent Kssis interim managing director of XBT Provider AB, the Swedish company that launched the world's first bitcoin-backed exchange traded note (ETN).
Upvote Downvote

 
BRIEF-Mineral Mountain announces C$1 million non-brokered private placement

2017-03-13 reuters
* Non-brokered private placement of up to 3.63 million units of company to be sold at a price of C$0.275 per unit Source text for Eikon: Further company coverage:
Upvote Downvote

 
Mexico retail group ANTAD says same-store Feb sales up 2.7 pct

2017-03-13 reuters
MEXICO CITY, March 13 Mexico's retailers' association said on Monday that sales at stores open at least a year rose 2.7 percent in February compared to same month a year earlier.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...